Manage
Pharmaceutical Industry
search
Pharmaceutical Industry
, Drug Manufacturer, Big Pharma
Efficacy
Manipulation of Pharma Sponsored Study Results
Background
Pharmaceutical companies have decades of work, billions of dollars of potential sales hinging on study results
Newly introduced drugs are typically backed by studies that overestimate benefit and underestimate risk
Lexchin (2003) BMJ 326(7400): 1167 +PMID:12775614 [PubMed]
Schott (2010) Dtsch Arztebl Int 107(16):279-85 +PMID:20467553 [PubMed]
Schott (2010) Dtsch Arztebl Int 107(17):295-301 +PMID:20490338 [PubMed]
Methods of data manipulation
Negative studies are not published
Pharmaceutical supported studies with negative results are eliminated
Journals are pressured not to publish Independent studies with negative results
Tsai (2003) Int J Health Serv 33(4): 751–768 +PMID:14758858 [PubMed]
Adverse outcomes are suppressed in published reports
http://www.breggin.com/antidepressant-drugs-resources/Breggin2006a-Paxil-GSK-Sepcial-Report-Part-I.pdf
Control group manipulation
Limit the
Placebo Effect
(patients can infer that they are not taking the active drug)
Statistical manipulation
Pharma employs talented biostatisticians
Selective study duration
Limit trial duration to time where toxicity is not yet evident, and effects have not yet dissipated
Resources
Goldacre (2014) Bad Pharma
Paid link to Amazon.com (ISBN 0865478066)
References
Lin and Paradis in Herbert (2018) EM:Rap 18(9): 7-8
Type your search phrase here